701 West Main Street, Suite 200 Durham, NC 27701, USA
(919) 980-8555


Falcon CEO Susan Nichols Discusses Regenerative Medicine Game Changers with Kineticos

On potential catalysts that could drive a landscape change in regenerative medicine approaches, Susan Nichols says: I’m starting to see the manufacturing enhancements that were promised in the past, come to market with unique capabilities and efficiencies. Before, closed automated systems were a dream and they are now starting to become a reality in increments.…
Read more

Falcon Therapeutics Awarded $1.5 Million Grant to Advance Cell Therapy to Patients and Potentially Save Lives

Falcon Therapeutics, a Durham, NC based gene-modified cell therapy company, has been awarded a nearly $1,500,000 Phase II Small Business Technology Transfer (SBTT) grant from the National Institutes of Health (NIH) to deliver life-saving therapies to patients fighting Glioblastoma (GBM), the most common primary brain tumor and one of the deadliest and most difficult cancers…
Read more

Falcon Therapeutics CEO Susan Nichols Discusses Top 10 Cell and Gene Therapy Milestones at Phacilitate Conference

Susan Nichols, CEO of cell therapy firm Falcon Therapeutics discussed the Top 10 Cell and Gene Therapy Milestones at the 2019 Phacilitate conference in Miami, Florida. Read the full article at BioProcess International.